JL18008
/ Jecho Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 03, 2026
Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders
(clinicaltrials.gov)
- P1 | N=52 | Not yet recruiting | Sponsor: Jecho Biopharmaceuticals Co., Ltd.
New P1 trial • Human Immunodeficiency Virus • Infectious Disease • CD4
1 to 1
Of
1
Go to page
1